Viewing Gene With Clinical Trials Data

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Report Bug Request Feature
Gene Data From HGNC: https://www.genenames.org/download/statistics-and-files/
Symbol: RUNX1
Name: RUNX family transcription factor 1
Location: 21q22.12
Locus Group: protein-coding gene
Gene Type: Protein Coding
Locus Type: gene with protein product
ID+ Clinical Trials CompTox DrugMatrix Conditions Design Enrollment Locations Outcomes
Clinical Trials Data: https://classic.clinicaltrials.gov/api/gui/ref/download_all

Clinical Studies

NCT Number Status Brief Title View
NCT03117751 Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma View
NCT03280888 Relevance of Peripheral Cells in the Pathophysiology of Chronic Myelomonocytic Leukemia CMML View
NCT05339204 The Role of Allo-HSCT in MRD-negative Patients With AML Under the Age of 60 Years in the First Complete Remission View
NCT02450877 A Study of Safety Efficacy and Pharmacodynamics of Azacitidine in Children and Young Adults With Acute Myeloid Leukemia View
NCT03894852 SRSF2 Gene Mutation in Patients With t-MDSAML View
NCT01329471 Functional Role of RUNX1 Mutations in the Etiology of Acute Myeloid Leukemia AML View
NCT04874194 Omacetaxine and Venetoclax for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Harboring Mutant RUNX1 View
NCT03854318 Longitudinal Studies of Patient With FPDMM View
NCT02926586 Fludarabine and Cytarabine Versus High-dose Cytarabine for CBF-AML View
NCT04311060 Genetic and Molecular Characteristics of Mexican Adults With Acute Myeloid Leukemia a Prospective Multicentric Study View
NCT06261060 Low-Dose Sirolimus to Increase Hematopoietic Function in Patients With RUNX1 Familial Platelet Disorder View
NCT06649227 Study Investigating the Safety of CD19 CAR-T Cells in RelapsedRefractory AML Expressing CD19 View
NCT06090669 Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency View
NCT06414889 Protocol Title Safety and Feasibility of Autologous CD34 Hematopoietic Stem Cells Mobilization and Apheresis in Participants With RUNX1 Familial Platelet Disorder View
NCT03311815 Diagnostic Platform to Perform Centralized and Standardized Rapid Molecular Diagnosis by Next Generation Sequencing NGS in Patients Diagnosed With Acute Myeloid Leukemia View